Recent research shows compounds like P7C3-A20 restore NAD+ levels, reversing Alzheimer’s pathology in mice, with early clinical trials indicating safety and potential efficacy in humans. Breakth...
A 2025 research paper finds that obese individuals with low choline levels face increased Alzheimer’s disease risk due to inflammation and neuronal damage, highlighting dietary interventions. Re...
New research links impaired glymphatic drainage to early cognitive decline, with DTI-ALPS imaging enabling early detection. Lifestyle interventions like sleep and exercise show promise in supporting b...
The Phase 3 failure of semaglutide in Alzheimer’s disease highlights challenges in repurposing GLP-1 agonists, urging a shift towards biomarker-driven and personalized approaches in neurodegener...
Recent evidence shows moderate walking reduces tau buildup and inflammation, slowing Alzheimer’s progression. Epidemiological studies highlight dose-response benefits for accessible preventive h...
